TY - JOUR
T1 - The association of arsenic exposure and metabolism with type 1 and type 2 diabetes in youth
T2 - The search case-control study
AU - Grau-Pérez, Maria
AU - Kuo, Chin Chi
AU - Spratlen, Miranda
AU - Thayer, Kristina A.
AU - Mendez, Michelle A.
AU - Hamman, Richard F.
AU - Dabelea, Dana
AU - Adgate, John L.
AU - Knowler, William C.
AU - Bell, Ronny A.
AU - Miller, Frederick W.
AU - Liese, Angela D.
AU - Zhang, Chongben
AU - Douillet, Christelle
AU - Drobná, Zuzana
AU - Mayer-Davis, Elizabeth J.
AU - Styblo, Miroslav
AU - Navas-Acien, Ana
N1 - Publisher Copyright:
© 2017 by the American Diabetes Association.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - OBJECTIVE Little is known about arsenic and diabetes in youth. We examined the association of arsenic with type 1 and type 2 diabetes in the SEARCH for Diabetes in Youth Case-Control (SEARCH-CC) study. Because one-carbon metabolism can influence arsenic metabolism, we also evaluated the potential interaction of folate and vitamin B12 with arsenic metabolism on the odds of diabetes. RESEARCH DESIGN AND METHODS Six hundred eighty-eight participants <22 years of age (429 with type 1 diabetes, 85 with type 2 diabetes, and 174 control participants) were evaluated. Arsenic species (inorganic arsenic [iAs], monomethylated arsenic [MMA], dimethylated arsenic [DMA]), and one-carbon metabolism biomarkers (folate and vitamin B12) were measured in plasma.We used the sumof iAs,MMA, andDMA (∑As) and the individual species as biomarkers of arsenic concentrations and the relative proportions of the species over their sum (iAs%, MMA%, DMA%) as biomarkers of arsenic metabolism. RESULTS Median∑As, iAs%, MMA%, and DMA% were 83.1 ng/L, 63.4%, 10.3%, and 25.2%, respectively. ∑As was not associated with either type of diabetes. The fully adjusted odds ratios (95% CI), rescaled to compare a difference in levels corresponding to the interquartile range of iAs%,MMA%, and DMA%, were 0.68 (0.50-0.91), 1.33 (1.02-1.74), and 1.28 (1.01-1.63), respectively, for type 1 diabetes and 0.82 (0.48-1.39), 1.09 (0.65-1.82), and 1.17 (0.77-1.77), respectively, for type 2 diabetes. In interaction analysis, the odds ratio of type 1 diabetes by MMA% was 1.80 (1.25-2.58) and 0.98 (0.70-1.38) for participants with plasma folate levels above and below the median (P for interaction = 0.02), respectively. CONCLUSIONS Low iAs% versus high MMA% and DMA% was associated with a higher odds of type 1 diabetes, with a potential interaction by folate levels. These data support further research on the role of arsenicmetabolismin type 1 diabetes, including the interplay with one-carbon metabolism biomarkers.
AB - OBJECTIVE Little is known about arsenic and diabetes in youth. We examined the association of arsenic with type 1 and type 2 diabetes in the SEARCH for Diabetes in Youth Case-Control (SEARCH-CC) study. Because one-carbon metabolism can influence arsenic metabolism, we also evaluated the potential interaction of folate and vitamin B12 with arsenic metabolism on the odds of diabetes. RESEARCH DESIGN AND METHODS Six hundred eighty-eight participants <22 years of age (429 with type 1 diabetes, 85 with type 2 diabetes, and 174 control participants) were evaluated. Arsenic species (inorganic arsenic [iAs], monomethylated arsenic [MMA], dimethylated arsenic [DMA]), and one-carbon metabolism biomarkers (folate and vitamin B12) were measured in plasma.We used the sumof iAs,MMA, andDMA (∑As) and the individual species as biomarkers of arsenic concentrations and the relative proportions of the species over their sum (iAs%, MMA%, DMA%) as biomarkers of arsenic metabolism. RESULTS Median∑As, iAs%, MMA%, and DMA% were 83.1 ng/L, 63.4%, 10.3%, and 25.2%, respectively. ∑As was not associated with either type of diabetes. The fully adjusted odds ratios (95% CI), rescaled to compare a difference in levels corresponding to the interquartile range of iAs%,MMA%, and DMA%, were 0.68 (0.50-0.91), 1.33 (1.02-1.74), and 1.28 (1.01-1.63), respectively, for type 1 diabetes and 0.82 (0.48-1.39), 1.09 (0.65-1.82), and 1.17 (0.77-1.77), respectively, for type 2 diabetes. In interaction analysis, the odds ratio of type 1 diabetes by MMA% was 1.80 (1.25-2.58) and 0.98 (0.70-1.38) for participants with plasma folate levels above and below the median (P for interaction = 0.02), respectively. CONCLUSIONS Low iAs% versus high MMA% and DMA% was associated with a higher odds of type 1 diabetes, with a potential interaction by folate levels. These data support further research on the role of arsenicmetabolismin type 1 diabetes, including the interplay with one-carbon metabolism biomarkers.
UR - http://www.scopus.com/inward/record.url?scp=85008196499&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008196499&partnerID=8YFLogxK
U2 - 10.2337/dc16-0810
DO - 10.2337/dc16-0810
M3 - Article
C2 - 27810988
AN - SCOPUS:85008196499
SN - 0149-5992
VL - 40
SP - 46
EP - 53
JO - Diabetes care
JF - Diabetes care
IS - 1
ER -